Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jost

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer CellsVittoria Massafra, Sofia Tundo, Aline Dietzig, et al.
The American Journal of Gastroenterology|November 26, 2003
A prospective, blinded study of diagnostic esophagoscopy with a superthin, stand-alone, battery-powered esophagoscopeMahesh S Mokhashi, Stephan M Wildi, Tammy F Glenn, et al.
Peerj|July 26, 2019
Marine biodiversity from zero to a thousand meters at Clipperton Atoll (Île de La Passion), Tropical Eastern PacificAlan M Friedlander, Jonatha Giddens, Enric Ballesteros, et al.
Protein Engineering, Design & Selection : PEDS|September 11, 2019
P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutationDiana Darowski, Christian Jost, Kay Stubenrauch, et al.
Gastrointestinal Endoscopy|March 23, 2010
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)Christian Jost, Janek Binek, Jan C Schuller, et al.
Mabs|November 2, 2020
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulinsChristian Jost, Diana Darowski, John Challier, et al.
Nature Biotechnology|September 18, 2012
Direct identification of ligand-receptor interactions on living cells and tissuesAndreas P Frei, Ock-Youm Jeon, Samuel Kilcher, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumorsSophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safetyKatrin Friedrich, Jan Rh Hanauer, Steffen Prüfer, et al.
Molecular Therapy Oncolytics|April 28, 2016
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptorsJan Rh Hanauer, Lisa Gottschlich, Dennis Riehl, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer CellsVittoria Massafra, Sofia Tundo, Aline Dietzig, et al.
The American Journal of Gastroenterology|November 26, 2003
A prospective, blinded study of diagnostic esophagoscopy with a superthin, stand-alone, battery-powered esophagoscopeMahesh S Mokhashi, Stephan M Wildi, Tammy F Glenn, et al.
Peerj|July 26, 2019
Marine biodiversity from zero to a thousand meters at Clipperton Atoll (Île de La Passion), Tropical Eastern PacificAlan M Friedlander, Jonatha Giddens, Enric Ballesteros, et al.
Protein Engineering, Design & Selection : PEDS|September 11, 2019
P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutationDiana Darowski, Christian Jost, Kay Stubenrauch, et al.
Gastrointestinal Endoscopy|March 23, 2010
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)Christian Jost, Janek Binek, Jan C Schuller, et al.
Mabs|November 2, 2020
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulinsChristian Jost, Diana Darowski, John Challier, et al.
Nature Biotechnology|September 18, 2012
Direct identification of ligand-receptor interactions on living cells and tissuesAndreas P Frei, Ock-Youm Jeon, Samuel Kilcher, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumorsSophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safetyKatrin Friedrich, Jan Rh Hanauer, Steffen Prüfer, et al.
Molecular Therapy Oncolytics|April 28, 2016
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptorsJan Rh Hanauer, Lisa Gottschlich, Dennis Riehl, et al.
Pageof 5